Short oxygen prebreathing and intravenous perfluorocarbon emulsion reduces morbidity and mortality in a swine saturation model of decompression sickness

Journal of Applied Physiology

Volumn 102, Issue 3, 2007, Pages 1099-1104

  Dainer, Hugh ^a   Nelson, John ^a   Brass, Kathryn ^a   Montcalm Smith, Elizabeth ^a   Mahon, Richard ^a   Temple, D ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

Disabled submarine; Nitrogen

Indexed keywords

FLUOROCARBON; INERT GAS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BREATHING; CONTROLLED STUDY; DECOMPRESSION SICKNESS; MALE; MORBIDITY; MORTALITY; NONHUMAN; OXYGEN SATURATION; OXYGEN THERAPY; PRIORITY JOURNAL; SEIZURE; SWINE;

ANIMALS; BODY WEIGHT; DECOMPRESSION SICKNESS; FLUOROCARBONS; INFUSIONS, INTRAVENOUS; MALE; OXYGEN; SEIZURES; SWINE;

EID: 33847727495     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01539.2005     Document Type: Article

References (38)

1. Barratt DM, Harch PG, Van Meter K. Decompression illness in divers: a review of the literature. Neurologist 8: 186-202, 2002.
2. Behnke AR. The isobaric (oxygen window) principle of decompression. In: The New Thrust Seaward: Transactions of the Third Annual MTS Conference and Exhibit. San Diego, CA: MTS, 1967, p. 213-228.
3. Blogg SL, Gennser M, Loveman GA, Seddon FM, Thacker JC, White MG. The effect of breathing hyperoxic gas during simulated submarine escape on venous gas emboli and decompression illness. Undersea Hyperb Med 30: 163-174, 2003.
4. Cabrales P, Tsai AG, Frangos JA, Briceno JC, Intaglietta M. Oxygen delivery and consumption in the microcirculation after extreme hemodilution with perfluorocarbons. Am J Physiol Heart Circ Physiol 287: H320-H330, 2004.
5. Curley MD, Ryder S, Harabin A, Weathersby P, Horn WG, Kelleher PC, Scholley B, Falloway T, Shake C, Wray DD, Lehner C, Flynn ET, Webert W, Schmidt T, Thalmann ED, Lambertsen CJ, Ball R, Francis J, McLean D, Clarke J. Medical preparedness for submarine escape and rescue. In: Medical Preparedness for Submarine Escape and Rescue, edited by Francis TJR and Curley MD. Groton, CT: Naval Submarine Medical Research Laboratory, 1997.
6. Dromsky DM, Spiess BD, Fahlman A. Treatment of decompression sickness in swine with intravenous perfluorocarbon emulsion. Aviat Space Environ Med 75: 301-305, 2004.
7. Dromsky DM, Toner CB, Survanshi S, Fahlman A, Parker E, Weathersby P. Natural history of severe decompression sickness after rapid ascent from air saturation in a porcine model. J Appl Physiol 89: 791-798, 2000.
8. Ersoz G, Ocakcioglu B, Bastug M, Ficicilar H, Yavuzer S. Platelet aggregation and release function in hyperbaric oxygenation. Undersea Hyperb Med 25: 229-232, 1998.
9. 2 biochemical decompression. Bull Math Biol 65: 747-766, 2003.
10. Faithfull NS. Mechanisms and efficacy of fluorochemical oxygen transport and delivery. Artif Cells Blood Substit Immobil Biotechnol 22: 181-197, 1994.
11. Geyer RP. Fluorocarbon-polyol artificial blood substitutes. N Engl J Med 289: 1077-1082, 1973.
12. Harvey CA, Stetson DM, Burns AC, Weathersby PK, Parker JW, Mole DM. Pressurized Submarine Rescue: A Manual for Undersea Medical Officers. Groton, CT: Naval Submarine Medical Research Laboratory, 1992.
13. Hjelde A, Hjelstuen M, Haraldseth O, Martin D, Thom R, Brubakk O. Hyperbaric oxygen and neutrophil accumulation/tissue damage during permanent focal cerebral ischaemia in rats. Eur J Appl Physiol 86: 401-405, 2002.
14. Joiner JT. (Editor). Appendix VI: Saturation treatment tables. In: NOAA Diving Manual: Diving for Science and Technology. Flagstaff, AZ: NOAA, 2001.
15. Kaul DK, Liu X, Nagel RL. Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature. Blood 98: 3128-3131, 2001.
16. Kerins DM. Role of the Perfluorocarbon Fluosal-DA in coronary angioplasty. Am J Med Sci 307: 218-221, 1994.
17. Latson G, Flynn E, Gerth W, Thalmann E, Maurer J, Lowe M. Accelerated Decompression Using Oxygen for Submarine Rescue. Summary Report and Operational Guidance (Technical Report). Panama City, FL: Navy Experimental Diving Unit, 2000.
18. Leese PT, Noveck RJ, Shorr JS, Woods CM, Flaim KE, Keipert PE. Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers. Anesth Analg 91: 804-811, 2000.
19. Lillo RS, Himm JF, Weathersby PK, Temple DJ, Gault KA, Dromsky DM. Using animal data to improve prediction of human decompression risk following air-saturation dives. J Appl Physiol 93: 216-226, 2002.
20. Lowe KC. Perfluorinated blood substitutes and artificial oxygen carriers. Blood Rev 13: 171-184, 1999.
21. Lundgren C, Bergoe G, Olszowka A, Tyssebotn I. Tissue nitrogen elimination in oxygen-breathing pigs is enhanced by fluorocarbon-derived intravascular micro-bubbles. Undersea Hyperb Med 32: 215-226, 2005.
22. Maas P. The Rescue. New York: Harper and Row, 1967, p. 239.
23. Mahon RT, Dainer HM, Nelson JW. Decompression sickness in a swine model: isobaric denitrogenation and perfluorocarbon at depth. Aviat Space Environ Med 77: 8-12, 2006.
24. Martin JD, Thom SR. Vascular leukocyte sequestration in decompression sickness and prophylactic hyperbaric oxygen therapy in rats. Aviat Space Environ Med 73: 565-569, 2002.
25. NAVSEA. U.S. Navy Diving Manual (Revision 4 with Change A). Washington, DC: Naval Sea Systems Command, 2001.
26. Noveck RJ, Shannon EJ, Leese PT, Shorr JS, Flaim KE, Keipert PE, Woods CM. Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers. Anesth Analg 91: 812-822, 2000.
27. Parker EC, Ball R, Tibbles PM, Weathersby PK. Escape from a disabled submarine: decompression sickness risk estimation. Aviat Space Environ Med 71: 109-114, 2000.
28. Philp RB, Inwood MJ, Warren BA. Interactions between gas bubbles and components of the blood: implications in decompression sickness. Aerospace Med 43: 946-953, 1972.
29. Spiess BD, McCarthy RJ, Tuman KJ, Woronowicz AW, Tool KA, Ivankovich AD. Treatment of decompression sickness with a perfluorocarbon emulsion (FC-43). Undersea Biomed Res 15: 31-37, 1988.
30. Symons JD, Sun X, Flaim SF, del Balzo U. Perflubron emulsion improves tolerance to low-flow ischemia in isolated rabbit hearts. J Cardiovasc Pharmacol 34: 108-115, 1999.
31. Tetzlaff K, Shank ES, Muth CM. Evaluation and management of decompression illness - an intensivist's perspective. Intensive Care Med 29: 2128-2136, 2003.
32. Thom SR, Fisher D, Zhang J, Bhopale VM, Ohnishi ST, Kotake Y, Ohnishi T, Buerk DG. Stimulation of perivascular nitric oxide synthesis by oxygen. Am J Physiol Heart Circ Physiol 284: H1230-H1239, 2003.
33. 2. Am J Physiol Cell Physiol 272: C770-C777, 1997.
34. Vik A, Jenssen BM, Eftedal O, Brubakk AO. Relationship between venous bubbles and hemodynamic responses after decompression in pigs. Undersea Hyperb Med 20: 233-248, 1993.
35. Vorosmarti J Jr, Barnard EEP, Williams J, Hanson RdG. Nitrogen elimination during steady-state hyperbaric exposures. Undersea Biomed Res 5: 243-252, 1978.
36. Watenpaugh DE. Degassed liquids to prevent/treat decompression sickness. Med Hypotheses 60: 720-723, 2003.
37. Weathersby PK, Survanshi SS, Parker EC, Temple DJ, Toner CB. Estimated DCS Risks In Pressurized Submarine Rescue (Technical Report). Bethesda, MD: Naval Medical Research Center, 1999.
38. Webb JT, Pilmanis AA. A new preoxygenation procedure for extravehicular activity (EVA). Acta Astronaut 42: 115-122, 1998.